Yes, Humira (adalimumab) is an FDA-approved medication for the treatment of moderate to severe psoriasis. It works by targeting and inhibiting tumor necrosis factor-alpha (TNF-alpha), a protein involved in inflammatory processes, which can help reduce the symptoms and severity of psoriasis. Many patients experience significant improvement in their skin lesions and overall quality of life while using Humira. However, individual responses can vary, so it's important to consult a healthcare provider for personalized treatment options.
Copyright © 2026 eLLeNow.com All Rights Reserved.